China Grand Pharmaceutical and Healthcare Holdings Limited logo

China Grand Pharmaceutical and Healthcare Holdings Limited (0512)

Market Open
11 Aug, 08:00
HKEX HKEX
5. 26
HKD
-0.13
-2.4119%
HKD
28.78B Market Cap
- P/E Ratio
1.04% Div Yield
4.2M Volume
- Eps
5.39 HKD
Previous Close
Add Transaction
Day Range
5.25 5.43
Year Range
4.53 9.88
Want to track 0512 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0512 trading today lower at 5.26 HKD, a decrease of -2.4119% from yesterday's close, completing a monthly increase of 10.0418% or 0.48 HKD. Over the past 12 months, 0512 stock lost -33.1639%.
0512 pays dividends to its shareholders, with the most recent payment made on Jun 30, 2026. The next estimated payment will be in In 10 months on Jun 30, 2027 for a total of 0.169 HKD.
The last earnings report, released on Mar 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
China Grand Pharmaceutical and Healthcare Holdings Limited has completed 3 stock splits, with the recent split occurring on Dec 06, 2010.
The company's stock is traded on one exchange.

0512 Chart

People also search for

China Tourism Group Duty Free Corporation Limited
50.25 HKD
-0.9852%
Li Auto Inc.
49.46 HKD
+0.8153%
Geely Automobile Holdings Limited
17.86 HKD
-1.8681%
Prada S.p.A.
42.42 HKD
-2.6618%
Hansoh Pharmaceutical Group Co., Ltd.
33.76 HKD
-3.0442%

China Grand Pharmaceutical and Healthcare Holdings Limited (0512) FAQ

What is the stock price today?

The current price is 5.26 HKD.

On which exchange is it traded?

China Grand Pharmaceutical and Healthcare Holdings Limited is listed on HKEX.

What is its stock symbol?

The ticker symbol is 0512.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.04%.

What is its market cap?

As of today, the market cap is 28.78B.

Has China Grand Pharmaceutical and Healthcare Holdings Limited ever had a stock split?

China Grand Pharmaceutical and Healthcare Holdings Limited had 3 splits and the recent split was on Dec 06, 2010.

China Grand Pharmaceutical and Healthcare Holdings Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Chao Zhou CEO
HKEX Exchange
G210A7101 CUSIP
Hong Kong Country
12,614 Employees
12 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Grand Pharmaceutical Group Limited, originally known as China Grand Pharmaceutical and Healthcare Holdings Limited, operates as an investment holding entity dedicated to the pharmaceutical sector. Its business model encompasses the research and development, production, and distribution of a broad spectrum of pharmaceutical products and medical devices. The company is also involved in biotechnology and healthcare products, alongside the provision of pharmaceutical raw materials. With a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University for ophthalmic drug research and development, Grand Pharmaceutical Group Limited has positioned itself as a significant player in the pharmaceutical industry within and outside the People's Republic of China. Founded in 1995 and headquartered in Central, Hong Kong, the company has expanded its operational reach to include Asia, the United States, Europe, and other global markets.

Products and Services

  • Pharmaceutical Preparations and Medical Devices: The core offerings include respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology-related products. These cater to various therapeutic areas, emphasizing the company's commitment to addressing critical health issues.
  • Biotechnology and Healthcare Products: Apart from its focus on pharmaceuticals, the company also ventures into the development and sale of biotechnology and healthcare products, indicating its diversified approach in the health sector.
  • Pharmaceutical Raw Materials: Provision of essential raw materials for pharmaceutical production showcases Grand Pharmaceutical Group Limited’s integral role in supporting the broader pharmaceutical manufacturing ecosystem.
  • Chemical Medicine and Amino Acid Series Products: The company manufactures and sells an array of chemical medicine and amino acid series products, catering to both medical and nutritional needs.
  • Bio-pesticides and Additives: In its commitment to innovation and environmental sustainability, Grand Pharmaceutical Group Limited provides bio-pesticides and additives, reflecting its venture into agricultural sciences.
  • Disposal Surgical Products: The production and supply of disposal surgical products underscore the company's involvement in supporting healthcare facilities and ensuring safety and hygiene in medical procedures.
  • Chinese Medicine and Health Food Products: By offering Chinese medicine and health food products, the company pays homage to traditional therapeutic practices while meeting contemporary health and wellness needs.
  • Sewage Treatment Services: In addition to its pharmaceutical and healthcare initiatives, Grand Pharmaceutical Group Limited engages in sewage treatment services, demonstrating its commitment to environmental health and sustainability.

Contact Information

Address: The Center
Phone: -